Koninklijke Philips (NYSE:PHG – Get Free Report) has received a consensus rating of “Hold” from the four brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and one has issued a buy recommendation on the company.
A number of research analysts recently issued reports on PHG shares. StockNews.com upgraded shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research report on Thursday, February 8th. BNP Paribas downgraded Koninklijke Philips from an “outperform” rating to an “underperform” rating in a report on Wednesday, February 7th. JPMorgan Chase & Co. upgraded Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. Finally, UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a research note on Tuesday, April 30th.
Read Our Latest Stock Analysis on Koninklijke Philips
Koninklijke Philips Trading Up 1.0 %
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Sequoia Financial Advisors LLC purchased a new stake in Koninklijke Philips during the fourth quarter worth about $473,000. HighTower Advisors LLC lifted its stake in Koninklijke Philips by 73.9% in the third quarter. HighTower Advisors LLC now owns 28,270 shares of the technology company’s stock valued at $562,000 after purchasing an additional 12,010 shares during the last quarter. abrdn plc purchased a new position in Koninklijke Philips in the fourth quarter valued at approximately $2,677,000. Barclays PLC bought a new position in Koninklijke Philips during the third quarter valued at $2,310,000. Finally, Glenmede Trust Co. NA increased its position in Koninklijke Philips by 53.5% in the third quarter. Glenmede Trust Co. NA now owns 34,065 shares of the technology company’s stock worth $679,000 after buying an additional 11,875 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- Investing in Commodities: What Are They? How to Invest in Them
- MarketBeat Week in Review – 4/29 – 5/3
- What Do S&P 500 Stocks Tell Investors About the Market?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Are Dividend Challengers?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.